Clinically relevant predictions based on the results of this study may include decisions regarding the use of soluble iron in combination with erythropoietin and vitamin B12 or transfusion of packed red blood cells (pRBCs) in patients with anemia. This evidence concerns the gene EPO and anemia (phenotype).